These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6684613)

  • 1. Diurnal variation in cholesterol saturation of gall-bladder bile.
    Kupfer RM; Northfield TC
    Gut; 1983 Oct; 24(10):950-3. PubMed ID: 6684613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.
    Kupfer RM; Northfield TC
    Br J Clin Pharmacol; 1983 Jan; 15(1):114-6. PubMed ID: 6849734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a pharmacological dose of cholecystokinin on bile acid kinetics and biliary cholesterol saturation in man.
    Jazrawi RP; Northfield TC
    Gut; 1986 Apr; 27(4):355-62. PubMed ID: 3957106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
    Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
    Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
    Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
    Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A; Northfield TC
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting gall-stone dissolution rate during chenic acid therapy.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
    Iser JH; Murphy GM; Dowling RH
    Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
    Nakano K; Chijiiwa K
    Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
    Iser JH; Maton PN; Murphy GM; Dowling RH
    Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K
    Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
    Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones.
    Howard PJ; Gleeson D; Murphy GM; Dowling RH
    Gut; 1989 Jan; 30(1):97-103. PubMed ID: 2920932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstone formation and dissolution.
    Coyne MJ; Schoenfield LJ
    Prog Liver Dis; 1976; 5():622-35. PubMed ID: 775559
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of artificial depletion of the bile acid pool in man.
    Jazrawi RP; Bridges C; Joseph AE; Northfield TC
    Gut; 1986 Jul; 27(7):771-7. PubMed ID: 3732888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
    Northfield TC; Hofmann AF
    Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
    Smallwood RA; Jablonski P; Watts JM
    Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.